Dare Bioscience, Inc. — Director's Dealing 2018

Sep 11, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Dare Bioscience, Inc. (DARE)
CIK: 0001401914
Period of Report: 2018-09-07

Reporting Person: Walters-Hoffert Lisa (Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-09-07	Employee Stock Option (right to buy)	$1.01	A	100000	Acquired	2028-09-07	Common Stock (100000)	Direct

Footnotes

F1: This stock options vests and becomes exercisable in 48 equal monthly installments commencing on the one-month anniversary of the grant date, subject to the reporting person's continuous service to the issuer.